#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Osteomyelitis Pseudoxanthoma elasticum Erythema Paroxysmal nocturnal haemoglobinuria Squamous cell carcinoma of head and neck Erythema multiforme Lymphatic malformation Pyruvate kinase deficiency anaemia Infertility male Congenital hypotransferrinaemia Stevens-Johnson syndrome Becker's muscular dystrophy Monogenic diabetes Systemic sclerosis pulmonary Colitis ulcerative More trials…

    Learn about Rare Diseases

    Von Willebrand’s disease – Diagnostics Familial haemophagocytic lymphohistiocytosis – Basic Information Primary mediastinal large B-cell lymphoma – Trials in Disease Hereditary motor and sensory neuropathy – Treatment Glomerulonephritis membranous – Trials in Disease Mastocytosis – Basic Information Progressive multifocal leukoencephalopathy – Treatment Congenital hypotransferrinaemia – Trials in Disease Epidermolysis bullosa – Trials in Disease Marfan’s syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dasiglucagon Specific Nucleic Acid Sna-Papi Benzalkonium Chloride Pantothenate Sodium Mesenchymal Cells Abelacimab Calcium Lactate Gluconate Florquinitau (18F) Acp-017 Ianalumab Canis Familiaris (553) Caspofungin 7-Ethyl-10-Hydroxycamptothecin Colistimethate Sodium Human Immunoglobulin G Glibenclamide Diphenhydramine Hydrochloride Pivmecillinam Hydrochloride TAZAROTENE Iohexol More therapies…

    Learn about Your Condition

    Ebola disease Partial seizures Insulin resistance Arginase deficiency Ischaemic skin ulcer Persistent depressive disorder Reperfusion injury Prostatitis Escherichia coli Myxoid liposarcoma Hypotransferrinaemia Colorectal cancer Head and neck cancer stage IV Chondrocalcinosis Encephalopathy neonatal Lymphangiosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Breast cancer metastatic

  • Study on Detecting Tumor DNA in Blood for Patients with HR+, HER2 Low Metastatic Breast Cancer Using Trastuzumab Deruxtecan After Standard Therapy

    Recruiting

    2 1 1
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    France

  • Study on the Impact of Exercise and Atorvastatin on Advanced Breast, Ovarian, Prostate, and Kidney Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer metastatic
    • Breast cancer metastatic
    • Prostate cancer metastatic
    Investigated Drugs:
    • Atorvastatin
    Finland

  • Study on zAvatar Test for Treatment Decisions in Relapsed Ovarian Cancer and Metastatic Breast Cancer Using Palbociclib and Drug Combination for Eligible Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer recurrent
    • Breast cancer metastatic
    • Ovarian cancer
    Investigated Drugs:
    • Mirvetuximab Soravtansine
    • Eribulin Mesylate
    • Doxorubicin Hydrochloride, Liposomal
    Portugal

  • Study on Zanidatamab and Chemotherapy for Patients with Metastatic HER2-Positive Breast Cancer After Trastuzumab Deruxtecan Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Breast cancer
    Investigated Drugs:
    • Eribulin Mesylate
    • Capecitabine
    • Gemcitabine Hydrochloride
    Austria Belgium France Germany Greece Italy +2

  • Study on the Safety and Effects of Vosilasarm Alone and in Combination for Patients with Relapsed Advanced or Metastatic Breast Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Vosilasarm
    • Elacestrant
    Spain

  • Study on Long-Term Safety of Trastuzumab Deruxtecan for Patients with Advanced HER2-Positive or HER2-Mutated Solid Tumors

    Recruiting

    3 1 1
    Investigated Diseases:
    • HER2 positive gastric cancer
    • Breast cancer metastatic
    • HER2 positive breast cancer
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    Belgium France Italy Spain
Previous Page
1 2 3 4 5 … 14
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!